Yes, Regence BlueCross BlueShield may cover Spravato (esketamine) for eligible adults with certain forms of depression. According to Regence's official medication policy, most plans require prior authorization before approving treatment.
Understanding Regence BlueCross BlueShield Spravato coverage can help you prepare for treatment, including eligibility requirements, prior authorization, and potential costs. Coverage depends on your diagnosis, medical documentation, and specific insurance benefits.
At Etherios Therapy, we provide personalized Spravato treatment in Orem, Utah. Our team can help you explore your insurance benefits and understand the steps toward receiving care.
Regence Coverage for Spravato
Does Regence cover Spravato? Yes, Regence BlueCross BlueShield recognizes Spravato as medically necessary when patients meet its published coverage criteria. Its official medication policy, dru605, outlines eligibility requirements, prior authorization, and continued treatment coverage.
The Regence Spravato medication policy, effective April 1, 2026, identifies two qualifying conditions:
Treatment-resistant major depressive disorder (MDD).
Depressive symptoms in adults with major depressive disorder who have acute suicidal thoughts or behaviors.
The policy also explains that most Regence contracts require prior authorization for Spravato.
This means your healthcare provider generally submits information to Regence for review before treatment begins.
Regence uses these criteria to guide coverage decisions. Your specific insurance contract determines which benefits are available.
For patients exploring Spravato, this published policy provides a useful starting point for understanding potential coverage.
Spravato Eligibility Requirements
Regence considers Spravato medically necessary for new patients who meet its diagnosis and prescribing requirements. Your psychiatric provider helps establish eligibility through an evaluation and supporting medical records.
Under Regence's April 2026 policy, Spravato must be prescribed by or in consultation with a board-certified psychiatric mental health provider.
This may include a psychiatrist, psychiatric mental health nurse practitioner, or psychologist with prescribing authority under applicable state law.
Your provider must also confirm that you have one of the qualifying diagnoses listed in the policy.
For treatment-resistant depression, your medical history helps your provider determine whether the diagnosis applies.
One important detail is that Regence's current policy does not list a separate requirement to try two antidepressants before approving Spravato.
Although previous medication experiences remain relevant to your clinical evaluation, the published coverage criteria focus on your diagnosis and qualified psychiatric care.
Regence's current coverage policy also allows eligible patients with treatment-resistant depression to receive Spravato without requiring an oral antidepressant alongside it.
These updated requirements may give eligible patients additional treatment options.
Your provider can help determine how Regence's criteria apply to your medical history and treatment goals.
Spravato Prior Authorization
Most Regence BlueCross BlueShield plans require prior authorization for Spravato. This process allows Regence to review your diagnosis and medical information before making a coverage decision.
Your healthcare provider typically submits the authorization request with supporting clinical documentation.
For patients beginning treatment, Regence's policy calls for documentation confirming the qualifying diagnosis and involvement of an appropriate psychiatric provider.
The policy also outlines how long approved treatment may continue before another review.
Initial authorization allows up to 12 dose kits during eight weeks. After eight weeks, Regence reviews the authorization to determine whether continued treatment meets its requirements.
During this review, your provider documents how you are responding to treatment.
Regence considers signs of clinical benefit, such as improvement or stability in depression symptoms.
The insurer may approve continued treatment for up to 48 dose kits over 48 weeks. Continued authorization is reviewed at least every 48 weeks.
These reviews help support ongoing treatment based on your progress and medical needs.
At Etherios Therapy, our team can help coordinate the information needed for insurance review and explain what to expect during the approval process.
Spravato Medical Benefits
Regence's published medication policy places Spravato coverage under the medical benefit rather than the pharmacy benefit. This reflects how the medication is administered in a certified healthcare setting.
Spravato is a nasal spray that patients administer under medical supervision.
Because each treatment requires professional monitoring, Regence classifies Spravato as a provider-administered medication.
This detail is useful when checking your insurance benefits.
For example, reviewing your usual prescription drug coverage may not provide the complete information you need.
Instead, ask Regence about Spravato coverage under your medical benefits.
You should also confirm how your plan handles the clinical services associated with each appointment.
These may include medication administration, monitoring, and observation.
Understanding both medication and clinical service coverage helps you develop a clearer picture of your benefits before beginning treatment.
Spravato Out-of-Pocket Costs
Your out-of-pocket expenses for Spravato depend on your Regence plan's deductible, copayments, coinsurance, and covered services. Regence's medication policy establishes clinical coverage criteria rather than a fixed patient price.
Some plans use copayments, which are set amounts you pay for covered services. Other plans use coinsurance, which means you pay a percentage of the covered expense. Your deductible may also affect your responsibility, depending on how much you've already paid toward it.
Because Spravato involves supervised treatment, ask about both the medication and the services provided during each appointment.
Before starting treatment, you can contact Regence using the member services number on your insurance card.
Ask these questions to understand your benefits:
Does my plan cover Spravato under the medical benefit?
Is Etherios Therapy an in-network provider for my plan?
What deductible, copayment, or coinsurance applies?
Are medication administration and observation services covered?
Does my plan require any additional authorization steps?
You can also review your plan information through the Regence member website.
Having these answers can help you prepare for treatment with a clearer understanding of your coverage.
Spravato Financial Assistance
Eligible patients with commercial insurance may qualify for manufacturer savings programs that help reduce certain Spravato medication expenses. These programs have separate requirements from Regence insurance coverage.
The manufacturer offers the SPRAVATO withMe Savings Program to help qualifying patients manage eligible medication costs.
Savings depend on program rules, insurance eligibility, and applicable limits.
The SPRAVATO withMe Savings Program is designed for eligible adults with commercial or private insurance, including qualifying Regence plans. Patients with Medicare or Medicaid can explore other assistance resources based on their coverage and circumstances.
Program savings apply to eligible Spravato medication expenses. Your insurance benefits determine how related clinical services, including treatment observation, are covered.
You can review the official SPRAVATO withMe program requirements to learn about current eligibility and available assistance.
If you're considering treatment, ask about financial assistance while reviewing your Regence benefits.
Understanding these options together can help you plan for care and make informed financial decisions.
Your Next Step With Etherios
Regence BlueCross BlueShield provides a clear pathway to potential Spravato coverage for patients who meet its medical criteria. Understanding your diagnosis, authorization requirements, and medical benefits can help you move forward.
At Etherios Therapy, we understand how important it is to feel informed and supported when exploring depression treatment.
Our team can help you review your Regence coverage, understand the authorization process, and determine whether Spravato may be appropriate for your needs.
Ready to explore your options? Contact Etherios Therapy to ask about Spravato treatment and insurance verification.
We're here to help you take the next step with clarity, confidence, and compassionate care.
